For-profit organizations · Vancouver, British Columbia
Zucara Therapeutics Inc.
- Total value
- $950K
- Agreements
- 3
- Programs
- 1
- First and latest
- 2016–2020
Federal grants and contributions, agreements starting Jan 2006 to Oct 2026, each counted once at its latest amended value. Source: Treasury Board proactive disclosure, published October 11, 2026. Agreements under programs that mostly fund individuals are not listed under any name.
See this recipient’s records on the government’s search
Applying for the same funding? NRC IRAP Financial Assistance (apply through the funder’s page; no deadline stated). Deadlines, who can apply and who else got it.
By program
| Program | Department | Agreements | Total |
|---|---|---|---|
| Industrial Research Assistance Program – Contributions to Firms | National Research Council Canada | 1 | $550K |
Plus 2 agreements ($400K) where the department did not name a program.
By year
Funding by the year agreements started.
Show the numbers
| Year | Agreements | Total |
|---|---|---|
| 2016 | 1 | $50K |
| 2017 | 1 | $350K |
| 2018 | 0 | $0 |
| 2019 | 0 | $0 |
| 2020 | 1 | $550K |
Agreements
Newest first.
| Start | Program | What for | Value |
|---|---|---|---|
| Jun 2020 | Industrial Research Assistance Program – Contributions to FirmsNational Research Council Canada | Somatostatin 2 Receptor (SSTR2) Antagonists: Efficacy in managing Type 2 DiabetesContribution | $550,000 |
| Jun 2017 | Program not namedNational Research Council Canada | Contribution | $350,000 |
| Aug 2016 | Program not namedNational Research Council Canada | Contribution | $50,000 |